You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

BRETHAIRE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Brethaire patents expire, and when can generic versions of Brethaire launch?

Brethaire is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in BRETHAIRE is terbutaline sulfate. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Brethaire

A generic version of BRETHAIRE was approved as terbutaline sulfate by IMPAX LABS on June 26th, 2001.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for BRETHAIRE?
  • What are the global sales for BRETHAIRE?
  • What is Average Wholesale Price for BRETHAIRE?
Summary for BRETHAIRE
Drug patent expirations by year for BRETHAIRE
Recent Clinical Trials for BRETHAIRE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Yaakov BeilinPhase 2/Phase 3

See all BRETHAIRE clinical trials

US Patents and Regulatory Information for BRETHAIRE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis BRETHAIRE terbutaline sulfate AEROSOL, METERED;INHALATION 018762-001 Aug 17, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for BRETHAIRE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis BRETHAIRE terbutaline sulfate AEROSOL, METERED;INHALATION 018762-001 Aug 17, 1984 ⤷  Sign Up ⤷  Sign Up
Novartis BRETHAIRE terbutaline sulfate AEROSOL, METERED;INHALATION 018762-001 Aug 17, 1984 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for BRETHAIRE

See the table below for patents covering BRETHAIRE around the world.

Country Patent Number Title Estimated Expiration
Germany 1643296 ⤷  Sign Up
Norway 132866 ⤷  Sign Up
Norway 124723 ⤷  Sign Up
Switzerland 512428 Verfahren zur Herstellung von neuen 1-(3',5'-Dihydroxy- bzw. -acyloxy-phenyl)-2-aminoäthanolen und deren physiologisch verträglichen Säureadditionssalzen ⤷  Sign Up
Switzerland 510625 Verfahren zur Herstellung von neuen 1-(3',5'-Dihydroxy- bzw. -acyloxy-phenyl)-2-aminoäthanolen und deren physiologisch verträglichen Säureadditionssalzen (1-3 5-dihydroxyphenyl-2-alkylaminoethanols) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.